IL6 and endothelial dysfunction: First, fibrinogen may upregulate the proinflammatory cytokines interleukin-6 and tumor necrosis factor-α, thus exacerbating vascular inflammation and endothelial dysfunction; in turn, this could result in the formation of atherosclerotic plaques and plaque vulnerability (27).